Antisense-mediated exon skipping for X-linked Alport syndrome

DISEASE CATEGORY: Renal

INDICATION: Renal

Exon skipping therapy with an antisense oligonucleotide (ASO) targeting a truncating variant

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE